Skip to content
← Holders

Sanofi

What Sanofi reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1121404 · Filed Nov 5, 2026

Positions
16
Reported value
$629.9M
Opened
6
Closed
0
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$260.4M
    9 positions
  2. Dec 31, 2025$310.4M
    8 positions
  3. Mar 31, 2026$336M
    9 positions
  4. Jun 30, 2026$534M
    10 positions
  5. Sep 30, 2026$629.9M
    16 positions
SecuritySharesChangeValueOf portfolio
MGTXMeiraGTx Holdings plc
12.2M±0%$134.2M21.3%
INBXInhibrx Biosciences, Inc.
1.2M±0%$115.9M18.4%
NVAXNovavax Inc
6.9M±0%$74.4M11.8%
KRSAKorsana Biosciences, Inc.
2MNew$63.8M10.1%
ODTXOdyssey Therapeutics, Inc.
2M−0.1%$44.2M7%
ANABAnaptysbio, Inc
821.9K±0%$41.3M6.6%
AGMBAgomAb Therapeutics NV
2.8M±0%$30.9M4.9%
TRAXFirst Tracks Biotherapeutics, Inc.
821.9K±0%$29.1M4.6%
ETRAElectra Therapeutics, Inc.
2.5MNew$27.7M4.4%
ATTOAttovia Therapeutics, Inc.
1.1MNew$18.6M2.9%
LTGOLatigo Biotherapeutics, Inc.
672.8KNew$11.2M1.8%
IMRXImmuneering Corp
2.7M±0%$11.1M1.8%
MPLTMapLight Therapeutics, Inc.
912K±0%$9.3M1.5%
SCTXScribe Therapeutics, Inc.
500KNew$9.2M1.5%
SABSSAB Biotherapeutics, Inc.
2.2MNew$7M1.1%
QTTBQ32 Bio Inc.
244.1K±0%$2M0.3%